Author | Jordan Clark | OncLive

Author | Jordan Clark

Articles

Retesting for FLT3 Mutation Status in AML

July 09, 2019

Video

Jordan Clark, the chief commercial officer at Diaceutics, discusses FLT3 retesting in a relapsed acute myeloid leukemia setting.

x